Evidence map›Paper›PMID 31552188›Full record

ArticleFrontiers in oncology2019

Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.

Consuelo Amantini, Maria Beatrice Morelli, Massimo Nabissi, Francesco Piva, Oliviero Marinelli, Federica Maggi, Francesca Bianchi, Alessandro Bittoni, Rossana Berardi, Riccardo Giampieri and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma.International journal of molecular sciences · 2023
    Review
  12. The Prognostic Significance of Circulating Tumor Cells in Patients with Pancreatobiliary Cancer.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  13. Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.International journal of molecular sciences · 2023
    Review
  14. Technologies for Viable Circulating Tumor Cell Isolation.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Consuelo AmantiniSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Maria Beatrice MorelliSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Massimo NabissiSchool of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.
Francesco PivaDepartment of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy.
Oliviero MarinelliSchool of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
Federica MaggiDepartment of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Francesca BianchiOncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.
Alessandro BittoniOncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.
Rossana BerardiOncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.
Riccardo GiampieriOncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.
Giorgio SantoniSchool of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.
Università di Camerino · ITMarche Polytechnic University · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interest in liquid biopsy is growing because it could represent a non-invasive prognostic or predictive tool for clinical outcome in patients with pancreatic ductal adenocarcinoma (PDAC), an aggressive and lethal disease. In this pilot study, circulating tumor cells (CTCs), CD16 positive atypical CTCs, and CTC clusters were captured and characterized in the blood of patients with PDAC before and after palliative first line chemotherapy by ScreenCell device, immunohistochemistry, and confocal microscopy analysis. Gene profiles were performed by digital droplet PCR in isolated CTCs, five primary PDAC tissues, and three different batches of RNA from normal human pancreatic tissue. Welsh's

Indexed as

atypical CTCcirculating tumor cellsdigital droplet PCRgene signatureoverall survivalpancreatic cancer

Identifiers

PMID31552188
PMCPMC6746928
OpenAlexW2969316959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.